Pimozide Tablets Generics - Manufacturers & Suppliers
Orap®(US & EU)
| Product/Composition:- | Pimozide Tablets |
|---|---|
| Strength:- | 1 mg, 2 mg, 4 mg |
| Form:- | Oral Tablets |
| Reference Brands:- | Orap®(US & EU) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Pimozide is a typical antipsychotic that primarily works by blocking dopamine D2 receptors in the brain, reducing excessive dopaminergic activity. It is mainly used to treat chronic schizophrenia and delusional disorders. Additionally, pimozide is FDA-approved for managing Tourette’s syndrome to suppress severe motor and vocal tics when other treatments fail.
Pimozide tablets are FDA-approved in the United States for treating Tourette’s syndrome and are also indicated for chronic schizophrenia in select markets. In the EU, they are approved under strict guidelines for use in resistant schizophrenia and tic disorders. Both regions require compliance with GMP, pharmacovigilance, and detailed psychiatric safety data, especially concerning cardiac risks (QT prolongation). Registration demands a complete dossier including clinical data and labeling per FDA and EMA standards. To explore dossier-ready Pimozide tablets, APIs, and other available forms, visit Pharmatradz.com — your trusted B2B source for global pharmaceutical products.